awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q46069799-502D063F-A972-427A-9EBA-6F9ACC947486
Q46069799-502D063F-A972-427A-9EBA-6F9ACC947486
BestRank
Statement
http://www.wikidata.org/entity/statement/Q46069799-502D063F-A972-427A-9EBA-6F9ACC947486
Potential implications of matrix metalloproteinase-9 in assessment and treatment of coronary artery disease.
P2860
Q46069799-502D063F-A972-427A-9EBA-6F9ACC947486
BestRank
Statement
http://www.wikidata.org/entity/statement/Q46069799-502D063F-A972-427A-9EBA-6F9ACC947486
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
78a20cefaaaa166facdc8ad64d0e01a641e6a8d2
P2860
Antidiabetic PPAR gamma-activator rosiglitazone reduces MMP-9 serum levels in type 2 diabetic patients with coronary artery disease.